A Pan-Canadian, Retrospective Evaluation of MitraClip Safety and Efficacy

N/ACompletedNCT03592043

Population Health Research Institute1,191 enrolled

Overview

The PREMISE Registry is a retrospective, observational study that will evaluate the efficacy and safety of the MitraClip in real-world Canadian practice. It will include all patients who have undergone MitraClip implantation in Canada to date.

In addition to evaluating efficacy and safety, PREMISE will include a description of patient demographics, etiology of mitral regurgitation, co-morbidities, medication use and functional class. It will also compare re-hospitalization for heart failure 12 months prior and 12 months after the procedure.

Study Type

OBSERVATIONAL

Enrollment

1,191

Conditions

Mitral Regurgitation

Interventions

MitraClipDEVICE

Transcatheter Mitral Valve Repair with MitraClip

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patient has undergone percutaneous mitral valve repair with MitraClip Clip Delivery System in Canada Exclusion Criteria: * none

Locations (1)

Hamilton General Hospital

Hamilton, Ontario, Canada

Outcomes

Primary Outcomes

Mitral Regurgitation (MR) severity

Time frame: 12 months

Secondary Outcomes

Hospitalization for Heart Failure

Time frame: 12 months

All-cause mortality

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.